{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:07:19Z","timestamp":1753884439667,"version":"3.40.5"},"reference-count":80,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,14]]},"DOI":"10.14797\/mdcvj.1072","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T11:20:47Z","timestamp":1647256847000},"page":"47-58","source":"Crossref","is-referenced-by-count":4,"title":["It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis"],"prefix":"10.14797","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8303-9415","authenticated-orcid":false,"given":"Jean Michel","family":"Saad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5886-7999","authenticated-orcid":false,"given":"Ahmed Ibrahim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8571-2749","authenticated-orcid":false,"given":"Dixitha","family":"Anugula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8357-9729","authenticated-orcid":false,"given":"Yushui","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2676-3095","authenticated-orcid":false,"given":"Moath Said","family":"Alfawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2348-0484","authenticated-orcid":false,"given":"Mouaz H.","family":"Al-Mallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5826","reference":[{"journal-title":"Heart Fail Rev","article-title":"The genetics of cardiac amyloidosis","year":"2021","key":"key20220314072044_B1"},{"issue":"6","key":"key20220314072044_B2","first-page":"726","article-title":"Echocardiographic manifestations of infiltrative cardiomyopathy","volume":"70","year":"1976","journal-title":"A report of seven cases due to amyloid. Chest"},{"issue":"7","key":"key20220314072044_B3","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging","volume":"14","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"key20220314072044_B4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10741-014-9466-3","article-title":"Echocardiography in cardiac amyloidosis","volume":"20","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"12","key":"key20220314072044_B5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"10038","key":"key20220314072044_B6","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","year":"2016","journal-title":"Lancet"},{"journal-title":"Heart Fail Rev","article-title":"Echocardiographic assessment of cardiac amyloidosis","year":"2021","key":"key20220314072044_B7"},{"issue":"4","key":"key20220314072044_B8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004","volume":"79","year":"2005","journal-title":"Am J Hematol"},{"issue":"10","key":"key20220314072044_B9","first-page":"1128","article-title":"Left atrial structure and function in cardiac amyloidosis","volume":"18","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"key20220314072044_B10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0735-1097(85)80475-7","article-title":"Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival","volume":"6","year":"1985","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"key20220314072044_B11","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","year":"2014","journal-title":"Circulation"},{"issue":"24","key":"key20220314072044_B12","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","year":"2017","journal-title":"Eur Heart J"},{"issue":"10","key":"key20220314072044_B13","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ehjci\/jex034","article-title":"Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the \u201cWorking Group on myocardial and pericardial diseases\u201d of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography","volume":"18","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"key20220314072044_B14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0735-1097(89)90254-4","article-title":"Doppler characterization of left ventricular diastolic function in cardiac amyloidosis","volume":"13","year":"1989","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key20220314072044_B15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0002-9149(02)02277-4","article-title":"Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis","volume":"89","year":"2002","journal-title":"Am J Cardiol"},{"issue":"10","key":"key20220314072044_B16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.amjcard.2009.01.361","article-title":"Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis","volume":"103","year":"2009","journal-title":"Am J Cardiol"},{"issue":"5","key":"key20220314072044_B17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcmg.2018.02.016","article-title":"Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles","volume":"12","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"key20220314072044_B18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11886-010-0108-7","article-title":"Echocardiographic evaluation of cardiac amyloid","volume":"12","year":"2010","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"key20220314072044_B19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2014.994202","article-title":"The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis","volume":"22","year":"2015","journal-title":"Amyloid"},{"issue":"12","key":"key20220314072044_B20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/ehjci\/jew324","article-title":"Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy","volume":"18","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"key20220314072044_B21","article-title":"Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis","volume":"11","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"key20220314072044_B22","article-title":"Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters","volume":"10","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"key20220314072044_B23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","article-title":"Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers","volume":"60","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"key20220314072044_B24","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","article-title":"Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis","volume":"107","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"key20220314072044_B25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/heartjnl-2015-308657","article-title":"Prognostic implication of relative regional strain ratio in cardiac amyloidosis","volume":"102","year":"2016","journal-title":"Heart"},{"issue":"19","key":"key20220314072044_B26","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","year":"2012","journal-title":"Heart"},{"issue":"6","key":"key20220314072044_B27","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCIMAGING.113.000683","article-title":"Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy","volume":"6","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"key20220314072044_B28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcmg.2009.11.013","article-title":"Prognostic significance of strain Doppler imaging in light-chain amyloidosis","volume":"3","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"key20220314072044_B29","first-page":"273","article-title":"Cardiovascular magnetic resonance: twenty-first century solutions in cardiology","volume":"3","year":"2003","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"key20220314072044_B30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic Resonance in Transthyretin Cardiac Amyloidosis","volume":"70","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20220314072044_B31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"key20220314072044_B32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-014-9470-7","article-title":"Cardiovascular magnetic resonance for amyloidosis","volume":"20","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"4","key":"key20220314072044_B33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.amjcard.2015.05.021","article-title":"Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function","volume":"116","year":"2015","journal-title":"Am J Cardiol"},{"issue":"1","key":"key20220314072044_B34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12880-016-0173-5","article-title":"A case report in cardiovascular magnetic resonance: the contrast agent matters in amyloid","volume":"17","year":"2017","journal-title":"BMC Med Imaging"},{"issue":"16","key":"key20220314072044_B35","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"132","year":"2015","journal-title":"Circulation"},{"key":"key20220314072044_B36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12872-016-0311-6","article-title":"Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis","volume":"16","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"key20220314072044_B37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"key20220314072044_B38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2215\/CJN.02470607","article-title":"Presentation and outcome of patients with systemic amyloidosis undergoing dialysis","volume":"3","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"key20220314072044_B39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"key20220314072044_B40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"key20220314072044_B41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"key20220314072044_B42","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"key20220314072044_B43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"key20220314072044_B44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcmg.2017.02.012","article-title":"CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy","volume":"11","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"key20220314072044_B45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"key20220314072044_B46","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"key20220314072044_B47","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcmg.2016.01.036","article-title":"Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis","volume":"9","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"key20220314072044_B48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diii.2016.08.007","article-title":"Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging","volume":"98","year":"2017","journal-title":"Diagn Interv Imaging"},{"issue":"8","key":"key20220314072044_B49","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00330-011-2109-3","article-title":"Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis","volume":"21","year":"2011","journal-title":"Eur Radiol"},{"issue":"25","key":"key20220314072044_B50","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial Edema and Prognosis in Amyloidosis","volume":"71","year":"2018","journal-title":"J Am Coll Cardiol"},{"journal-title":"Heart Fail Rev","article-title":"99m Technetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions","year":"2021","key":"key20220314072044_B51"},{"issue":"24","key":"key20220314072044_B52","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"key20220314072044_B53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00003072-198103000-00003","article-title":"Bone scintigram in cardiac amyloidosis: a case report","volume":"6","year":"1981","journal-title":"Clin Nucl Med"},{"issue":"4 Pt 1","key":"key20220314072044_B54","first-page":"563","article-title":"Noninvasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy","volume":"103","year":"1982","journal-title":"Am Heart J"},{"issue":"7","key":"key20220314072044_B55","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00003072-198507000-00003","article-title":"Scintigraphic findings in primary amyloidosis of the heart and stomach","volume":"10","year":"1985","journal-title":"Clin Nucl Med"},{"issue":"3","key":"key20220314072044_B56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00003072-198503000-00004","article-title":"Scintigraphic characterization of amyloid cardiomyopathy","volume":"10","year":"1985","journal-title":"Clin Nucl Med"},{"issue":"12","key":"key20220314072044_B57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/BF00256851","article-title":"Soft-tissue uptake of 99mTc-diphosphonate in systemic AL amyloidosis","volume":"9","year":"1984","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"key20220314072044_B58","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20220314072044_B59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"key20220314072044_B60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis","volume":"22","year":"2015","journal-title":"Amyloid"},{"issue":"5","key":"key20220314072044_B61","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s12350-018-1235-6","article-title":"Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis","volume":"26","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"key20220314072044_B62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2020.1744553","article-title":"The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease","volume":"27","year":"2020","journal-title":"Amyloid"},{"issue":"1","key":"key20220314072044_B63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","article-title":"(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis","volume":"121","year":"2016","journal-title":"Ups J Med Sci"},{"issue":"6","key":"key20220314072044_B64","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis","volume":"13","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"key20220314072044_B65","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/13506129.2020.1798223","article-title":"Non-invasive detection and differentiation of cardiac amyloidosis using 99m Tc-pyrophosphate scintigraphy and 11 C-Pittsburgh compound B PET imaging","volume":"27","year":"2020","journal-title":"Amyloid"},{"issue":"1","key":"key20220314072044_B66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12350-016-0638-5","article-title":"Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR)","volume":"25","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"8","key":"key20220314072044_B67","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis","volume":"1","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"12","key":"key20220314072044_B68","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"key20220314072044_B69","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"key20220314072044_B70","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s12350-016-0768-9","article-title":"Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes","volume":"25","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"8","key":"key20220314072044_B71","article-title":"Regional Variability in Longitudinal Strain Across Vendors in Patients With Cardiomyopathy Due to Increased Left Ventricular Wall Thickness","volume":"12","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"journal-title":"Heart Fail Rev","article-title":"The utility of positron emission tomography in cardiac amyloidosis","year":"2021","key":"key20220314072044_B72"},{"issue":"2","key":"key20220314072044_B73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","year":"2013","journal-title":"J Nucl Med"},{"issue":"1","key":"key20220314072044_B74","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"key20220314072044_B75","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","article-title":"Diagnostic Accuracy of [11 C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis","volume":"13","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"key20220314072044_B76","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WAD.0b013e31821300bc","article-title":"Correlation of amyloid PET ligand florbetapir F 18 binding with A\u03b2 aggregation and neuritic plaque deposition in postmortem brain tissue","volume":"26","year":"2012","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"8","key":"key20220314072044_B77","article-title":"18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study","volume":"8","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"key20220314072044_B78","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"issue":"7","key":"key20220314072044_B79","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18 F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"key20220314072044_B80","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","article-title":"Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?","volume":"13","year":"2020","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T11:21:37Z","timestamp":1647256897000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1072\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3,14]]}},"alternative-id":["10.14797\/mdcvj.1072"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1072","relation":{},"ISSN":["1947-6108"],"issn-type":[{"type":"electronic","value":"1947-6108"}],"subject":[],"published":{"date-parts":[[2022]]}}}